Tokyo University Innovation Platform Development has invested 150 million yen in Instalimb, aiming to enhance the production of affordable, high-quality prosthetic limbs using 3D printing and AI in underserved markets.

Investment Overview

Tokyo University Innovation Platform Development Co., Ltd. (Headquarters: Bunkyo-ku, Tokyo; CEO: Kousuke Ueda), operating the Open Innovation Promotion Fund No. 1 (hereinafter referred to as "AOI Fund No. 1"), has made a significant investment of 150 million yen in Instalimb Co., Ltd. (Headquarters: Sumida-ku, Tokyo; CEO: Yasushi Tokushima), a company specializing in the production of prosthetic limbs using 3D printing and AI technologies in Japan, India, and the Philippines.

This investment in Instalimb is a collaborative effort involving several notable partners, including JIC Venture Growth Investments Co., Ltd. (Headquarters: Minato-ku, Tokyo; CEO: Hideki Yamamizuku), Mizuho Capital Co., Ltd. (Headquarters: Chiyoda-ku, Tokyo; CEO: Kunio Honda), IT-Farm Co., Ltd. (Headquarters: Shinjuku-ku, Tokyo; CEO: Morihiro Kurosaki), Mirai Creation Capital Co., Ltd. (Headquarters: Minato-ku, Tokyo; CEO: Nobufumi Takeuchi), Shinkin Capital Co., Ltd. (Headquarters: Chuo-ku, Tokyo; CEO: Zobun Suzuki), Libraight Partners Co., Ltd. (Headquarters: Chuo-ku, Tokyo; General Partner: Ken Ebihara), Darwin Ventures (Headquarters: Taipei; Representative: Yang Sheng-Ren), and the KVIF-1 Investment Fund (Kyocera Ventures).

Target Company Overview

Instalimb specializes in the production of prosthetic limbs utilizing advanced 3D printing technologies and AI for design optimization. The company aims to address significant healthcare challenges faced